See more : Foresight Sustainable Forestry Company PLC (FSF.L) Income Statement Analysis – Financial Results
Complete financial analysis of Grapefruit USA, Inc. (GPFT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Grapefruit USA, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Funeng Oriental Equipment Technology Co., Ltd. (300173.SZ) Income Statement Analysis – Financial Results
- MingZhu Logistics Holdings Limited (YGMZ) Income Statement Analysis – Financial Results
- Siem Industries S.A. (SEMUF) Income Statement Analysis – Financial Results
- CBD Global Sciences Inc. (CBDN.CN) Income Statement Analysis – Financial Results
- Veji Holdings Ltd. (VEJI.CN) Income Statement Analysis – Financial Results
Grapefruit USA, Inc. (GPFT)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.grapefruitblvd.com
About Grapefruit USA, Inc.
Grapefruit USA, Inc. operates as a manufacturer and distributor of cannabis products in California. It primarily provides Hourglass, a time release THC+CBD-infused topical cream through online store. The company was formerly known as Grapefruit Boulevard Investments, Inc. and changed its name to Grapefruit USA, Inc. in January 2020. Grapefruit USA, Inc. was founded in 2017 and is based in Wilmington, Delaware.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 200.00 | 39.79K | 588.96K | 3.67M | 451.20K | 181.50K | 41.83K | 33.08K | 220.81K | 398.27K | 1.05M | 1.05M | 1.07M | 1.18M | 1.36M | 1.76M | 1.32M | 1.39M | 2.10M | 1.28M |
Cost of Revenue | 237.11K | 504.03K | 1.12M | 3.39M | 708.57K | 183.46K | 14.26K | 10.25K | 169.12K | 163.14K | 585.79K | 585.79K | 505.87K | 532.16K | 700.25K | 662.23K | 910.13K | 676.62K | 1.07M | 638.11K |
Gross Profit | -236.91K | -464.25K | -530.17K | 280.47K | -257.37K | -1.96K | 27.57K | 22.84K | 51.69K | 235.14K | 466.75K | 466.75K | 562.75K | 645.32K | 664.64K | 1.09M | 413.65K | 709.32K | 1.02M | 642.55K |
Gross Profit Ratio | -118,456.00% | -1,166.86% | -90.02% | 7.64% | -57.04% | -1.08% | 65.90% | 69.03% | 23.41% | 59.04% | 44.34% | 44.34% | 52.66% | 54.81% | 48.70% | 62.28% | 31.25% | 51.18% | 48.81% | 50.17% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 2.40K | 108.79K | 200.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 1.78M | 1.32M | 1.62M | 6.32M | 1.65M | 2.70M | 1.50M | 1.36M | 1.86M | 1.86M | 0.00 | 2.47M | 2.51M | 2.28M | 2.47M | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 7.66K | 169.35K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 688.91K | 1.73M | 1.79M | 1.49M | 1.62M | 6.32M | 1.65M | 2.70M | 1.50M | 1.36M | 1.86M | 1.86M | 2.95M | 2.47M | 2.51M | 2.28M | 2.47M | 2.75M | 1.63M | 1.92M |
Other Expenses | 0.00 | 0.00 | 371.32K | 169.35 | 0.00 | -23.33K | 87.49K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 688.91K | 1.73M | 1.79M | 1.49M | 1.62M | 6.32M | 1.65M | 2.70M | 1.50M | 1.36M | 1.86M | 1.86M | 2.95M | 2.47M | 2.51M | 2.28M | 2.47M | 3.01M | 2.18M | 2.66M |
Cost & Expenses | 926.02K | 2.23M | 2.91M | 4.88M | 2.33M | 6.32M | 1.67M | 2.71M | 1.67M | 1.52M | 2.45M | 2.45M | 3.45M | 3.00M | 3.21M | 2.94M | 3.38M | 3.69M | 3.25M | 3.30M |
Interest Income | 0.00 | 0.00 | 1.68K | 2.10K | 571.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 1.11M | 1.47M | 1.68M | 2.10M | 571.05K | 679.69K | 1.17M | 2.89M | 1.19M | 6.06K | -975.99K | 975.99K | 423.37K | 55.15K | 52.37K | 51.79K | 70.86K | 68.78K | 85.84K | 78.12K |
Depreciation & Amortization | 186.72K | 73.61K | 741.60K | 171.06K | 63.98K | 24.71K | 3.40M | 1.00 | 0.00 | 0.00 | 0.00 | 7.57K | 10.52K | 7.82K | -3.10K | 17.91K | 15.23K | 14.62K | 15.23K | 16.39K |
EBITDA | -549.06K | -2.23M | -3.08M | -1.21M | -3.96M | -243.61K | 4.03M | -3.87M | -1.44M | -1.11M | -6.51M | 3.62M | -17.49M | -4.14M | -1.86M | -836.43K | -2.05M | -2.29M | -1.14M | -2.00M |
EBITDA Ratio | -274,528.00% | -5,330.14% | -110.77% | -28.19% | -401.68% | -3,495.76% | -3,680.43% | -8,084.79% | -657.31% | -281.19% | -132.57% | -131.85% | -222.14% | -154.04% | -135.15% | -66.48% | -158.52% | -164.31% | -29.14% | -111.43% |
Operating Income | -925.82K | -2.19M | -2.42M | -1.21M | -1.88M | -6.32M | -1.63M | -2.67M | -1.45M | -1.12M | -1.40M | -1.40M | -2.38M | -1.92M | -1.93M | -1.19M | -2.05M | -2.30M | -1.16M | -2.02M |
Operating Income Ratio | -462,911.00% | -5,515.16% | -410.14% | -32.85% | -415.86% | -3,482.91% | -3,889.59% | -8,084.79% | -657.31% | -281.19% | -132.57% | -132.57% | -223.13% | -163.16% | -141.24% | -67.50% | -154.99% | -165.95% | -55.19% | -157.44% |
Total Other Income/Expenses | -924.14K | -1.58M | -3.09M | -2.85M | -2.72M | 5.96M | 4.48M | -4.09M | -1.18M | 524.00 | -5.13M | 4.03M | -15.54M | -2.28M | 16.45K | 279.07K | -8.81K | 178.83K | -62.13K | 99.89K |
Income Before Tax | -1.85M | -3.78M | -5.51M | -4.06M | -4.60M | -8.13M | 2.85M | -6.76M | -2.63M | -1.12M | 800.00 | 2.64M | -17.93M | -4.20M | -1.91M | -906.13K | -2.06M | -2.12M | -1.22M | -1.92M |
Income Before Tax Ratio | -924,981.50% | -9,492.70% | -934.71% | -110.47% | -1,019.42% | -4,478.93% | 6,821.37% | -20,435.48% | -1,191.81% | -281.06% | 0.08% | 250.56% | -1,677.49% | -356.68% | -140.03% | -51.61% | -155.65% | -153.05% | -58.16% | -149.64% |
Income Tax Expense | 2.00 | 0.00 | 1.68M | -753.70 | 580.52K | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 |
Net Income | -1.85M | -3.78M | -7.19M | -4.06M | -5.18M | -8.13M | 2.85M | -6.76M | -2.63M | -1.12M | 2.64M | 2.64M | -17.93M | -4.20M | -1.91M | -906.93K | -2.06M | -2.12M | -1.22M | -1.92M |
Net Income Ratio | -924,981.50% | -9,492.70% | -1,220.69% | -110.47% | -1,148.08% | -4,479.37% | 6,819.46% | -20,437.90% | -1,192.18% | -281.26% | 250.49% | 250.49% | -1,677.56% | -356.75% | -140.09% | -51.65% | -155.71% | -153.10% | -58.19% | -149.70% |
EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.04 | -0.25 | 0.21 | -0.64 | -0.29 | -0.15 | 0.02 | 0.20 | -0.91 | -0.22 | -0.13 | -0.07 | -0.19 | -0.22 | -0.14 | -0.25 |
EPS Diluted | 0.00 | -0.01 | -0.01 | -0.01 | -0.04 | -0.25 | 0.18 | -0.64 | -0.29 | -0.15 | 0.02 | 0.07 | -0.91 | -0.22 | -0.13 | -0.07 | -0.19 | -0.22 | -0.14 | -0.25 |
Weighted Avg Shares Out | 901.40M | 670.66M | 515.34M | 498.23M | 140.04M | 32.12M | 13.83M | 10.64M | 9.20M | 7.49M | 149.75M | 25.00M | 19.63M | 18.84M | 14.73M | 12.18M | 10.60M | 9.72M | 8.53M | 7.76M |
Weighted Avg Shares Out (Dil) | 901.40M | 670.66M | 515.34M | 498.23M | 140.04M | 32.12M | 15.67M | 10.64M | 9.20M | 7.49M | 149.75M | 37.50M | 19.63M | 18.84M | 14.73M | 12.18M | 10.60M | 9.72M | 8.53M | 7.76M |
Grapefruit USA, Inc. Accepts Outside Director's Resignation
Grapefruit USA, Inc. Issues Further Update on Informal Acquisition Inquiry
Grapefruit USA, Inc. Issues Further Update Concerning Initial Informal Acquisition Inquiry
Grapefruit USA, Inc. Secures Trademark Protection for the ‘Hourglass' Name and Logo
Grapefruit USA, Inc. Issues Update Concerning Initial Informal Acquisition Inquiry, Announces Development of Memorandum of Understanding for Potential Joint Venture
Grapefruit USA, Inc. Announces Receipt of Initial Informal Acquisition Inquiry
Grapefruit USA, Inc. Announces Preliminary Revenue Growth of 714% for Calendar Year 2020 Over Calendar Year 2019
Grapefruit USA, Inc. CEO Comments on Positive Response of the Company's Publicly Traded Shares Since July 2020 Completion of Development of Grapefruit's Disruptive Hourglas(TM) Time Release THC+CBD Delivery Cream
Grapefruit USA, Inc. Provides Early 2021 Update Concerning It's Disruptive Hourglas(TM) Time Release THC+CBD Delivery Cream
Grapefruit USA, Inc. Announces Additional Retail Availability of its Patented Hourglass by Grapefruit(TM) Disruptive Time Release THC+Cannabinoid-loaded Delivery Cream in Greater Los Angeles
Source: https://incomestatements.info
Category: Stock Reports